Additionally, a trial among women with high risk of breast cancer due to mutations to breast cancer type 1 (BRCA1) susceptibility gene showed increased risk of all cancers and primary breast cancer in Se-supplemented arm compared to placebo [39]. This evidence concerns the gene BRCA1 and breast cancer.